Yohei Narita

1.3k total citations
32 papers, 827 citations indexed

About

Yohei Narita is a scholar working on Oncology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Yohei Narita has authored 32 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 14 papers in Pathology and Forensic Medicine and 11 papers in Epidemiology. Recurrent topics in Yohei Narita's work include Viral-associated cancers and disorders (25 papers), Lymphoma Diagnosis and Treatment (14 papers) and Cytomegalovirus and herpesvirus research (10 papers). Yohei Narita is often cited by papers focused on Viral-associated cancers and disorders (25 papers), Lymphoma Diagnosis and Treatment (14 papers) and Cytomegalovirus and herpesvirus research (10 papers). Yohei Narita collaborates with scholars based in Japan, United States and China. Yohei Narita's co-authors include Takayuki Murata, Teru Kanda, Tatsuya Tsurumi, Daisuke Kawashima, Atsuko Sugimoto, Hiroshi Kimura, Benjamin E. Gewurz, Bo Zhao, Shinichi Saito and Yoshitaka Sato and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Virology.

In The Last Decade

Yohei Narita

30 papers receiving 825 citations

Peers

Yohei Narita
Alexander M. Price United States
Ulrike Dirmeier United States
Amy Mauser United States
Dhananjay M. Nawandar United States
Ryan Murray United States
D. Clark United States
Gretchen L. Bentz United States
Andrea Lear United Kingdom
Yohei Narita
Citations per year, relative to Yohei Narita Yohei Narita (= 1×) peers Christopher B. Whitehurst

Countries citing papers authored by Yohei Narita

Since Specialization
Citations

This map shows the geographic impact of Yohei Narita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yohei Narita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yohei Narita more than expected).

Fields of papers citing papers by Yohei Narita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yohei Narita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yohei Narita. The network helps show where Yohei Narita may publish in the future.

Co-authorship network of co-authors of Yohei Narita

This figure shows the co-authorship network connecting the top 25 collaborators of Yohei Narita. A scholar is included among the top collaborators of Yohei Narita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yohei Narita. Yohei Narita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Endo, Akira, Koji Ito, Takeshi Yokoyama, et al.. (2025). Analysis of the characteristics and management of perforated peptic ulcer from 2011 to 2022: A multicenter and retrospective descriptive study. Annals of Gastroenterological Surgery. 9(3). 464–475.
2.
Yeo, Yao Yu, Xiang Liu, Yohei Narita, et al.. (2025). Epstein–Barr virus exploits desmocollin 2 as the principal epithelial cell entry receptor. Nature Microbiology. 10(11). 2781–2796.
3.
Leong, Merrin Man‐Long, Yohei Narita, Xiang Liu, et al.. (2025). Viral oncogene EBNALP regulates YY1 DNA binding and alters host 3D genome organization. EMBO Reports. 26(3). 810–835. 1 indexed citations
4.
Sugimoto, Atsuko, Takahiro Watanabe, Kazuhiro Matsuoka, et al.. (2023). Growth Transformation of B Cells by Epstein-Barr Virus Requires IMPDH2 Induction and Nucleolar Hypertrophy. Microbiology Spectrum. 11(4). e0044023–e0044023. 6 indexed citations
5.
Okuno, Yusuke, Yohei Narita, H. M. Abdullah Al Masud, et al.. (2021). RNAseq analysis identifies involvement of EBNA2 in PD-L1 induction during Epstein-Barr virus infection of primary B cells. Virology. 557. 44–54. 20 indexed citations
6.
Wang, Chong, Luyao Zhang, Liang‐Ru Ke, et al.. (2020). Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors. Nature Communications. 11(1). 6318–6318. 24 indexed citations
7.
Zhang, Yuchen, Chang Jiang, Stephen J. Trudeau, et al.. (2020). Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation. mBio. 11(5). 29 indexed citations
8.
Wang, Chong, Sizun Jiang, Liang‐Ru Ke, et al.. (2019). Genome-wide CRISPR-based gene knockout screens reveal cellular factors and pathways essential for nasopharyngeal carcinoma. Journal of Biological Chemistry. 294(25). 9734–9745. 10 indexed citations
9.
Narita, Yohei, et al.. (2018). BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon De Novo Infection. mSphere. 3(2). 26 indexed citations
10.
Ersing, Ina, Luís Nobre, Liang Wei Wang, et al.. (2017). A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells. Cell Reports. 19(7). 1479–1493. 71 indexed citations
11.
Yoshida, Masahiro, Takahiro Watanabe, Yohei Narita, et al.. (2017). The Epstein-Barr Virus BRRF1 Gene Is Dispensable for Viral Replication in HEK293 cells and Transformation. Scientific Reports. 7(1). 6044–6044. 8 indexed citations
12.
Yoshida, Masahiro, Takayuki Murata, Yohei Narita, et al.. (2017). Characterization of a Suppressive Cis-acting Element in the Epstein–Barr Virus LMP1 Promoter. Frontiers in Microbiology. 8. 2302–2302. 4 indexed citations
13.
Jiang, Sizun, Hufeng Zhou, Jun Liang, et al.. (2017). The Epstein-Barr Virus Regulome in Lymphoblastoid Cells. Cell Host & Microbe. 22(4). 561–573.e4. 89 indexed citations
14.
Watanabe, Takahiro, Takahiro Takano, Yohei Narita, et al.. (2015). Roles of Epstein-Barr virus BGLF3.5 gene and two upstream open reading frames in lytic viral replication in HEK293 cells. Virology. 483. 44–53. 12 indexed citations
15.
Watanabe, Takahiro, et al.. (2015). The Epstein–Barr virus BRRF2 gene product is involved in viral progeny production. Virology. 484. 33–40. 14 indexed citations
16.
Narita, Yohei, Atsuko Sugimoto, Daisuke Kawashima, et al.. (2015). A Herpesvirus Specific Motif of Epstein-Barr Virus DNA Polymerase Is Required for the Efficient Lytic Genome Synthesis. Scientific Reports. 5(1). 11767–11767. 8 indexed citations
17.
Narita, Yohei, et al.. (2015). Democratising party leadership selection in Japan and Taiwan. 105–127. 1 indexed citations
18.
Kanda, Teru, Naoki Horikoshi, Takayuki Murata, et al.. (2013). Interaction between Basic Residues of Epstein-Barr Virus EBNA1 Protein and Cellular Chromatin Mediates Viral Plasmid Maintenance. Journal of Biological Chemistry. 288(33). 24189–24199. 17 indexed citations
19.
Itaya, Tomotaka, Hideaki Kagami, K. Okada, et al.. (2009). Characteristic changes of periodontal ligament‐derived cells during passage. Journal of Periodontal Research. 44(4). 425–433. 54 indexed citations
20.
Igawa, Manabu, Yohei Narita, & Hiroshi Okochi. (2002). Selective Transport of Heavy Metal Ions across a Cation-Exchange Membrane with a Chelating Agent in the Receiving Phase. Bulletin of the Chemical Society of Japan. 75(10). 2269–2273. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026